Leucovorin (folinic acid) is used to prevent methotrexate toxicity by rescuing healthy cells from its effects.
Methotrexate inhibits dihydrofolate reductase, leading to folate depletion; leucovorin bypasses this blockade.
It is administered in high-dose methotrexate therapy to mitigate adverse effects.